Saturday, October 28, 2023

GC Aesthetics and Bimini Health Tech Form Strategic Partnership to Advance Breast Reconstruction Solutions Globally

 (BUSINESS WIRE) -- GC Aesthetics®, a long-established brand in breast aesthetics, and Bimini Health Tech (“Bimini”), a pioneer in healthcare solutions, are pleased to announce their groundbreaking Joint Venture partnership aimed at revolutionizing breast reconstruction worldwide.

This strategic collaboration combines GC Aesthetics' 40 years’ experience in design, manufacturing, and distribution of Silicone Breast Implants with Bimini's expertise in Breast Reconstruction innovation. The result: an unprecedented commitment to providing women with best-in-class solutions for breast reconstruction across the globe, including the USA, LATAM, EMEA, and APAC.

Under the umbrella of the Joint Venture named “OPALINE Aesthetics”, GC Aesthetics will deploy Bimini’s healthcare solutions outside the United States and Canada. Conversely, Bimini will commercialize selective GC Aesthetics’ breast reconstruction solutions into the United States which will complement its industry leading Puregraft portfolio of technologies that offer a broad set of solutions to plastic and reconstructive surgeons.

“We want to provide patients around the globe, state-of-the-art breast reconstruction solutions with a demonstrated best in class safety profile”, said Carlos Reis Pinto, CEO of GC Aesthetics. “The combination of Bimini and GCA portfolios will not only expand patient access to broader solutions but it will also lead to the development of new technologies which will improve the standard of care in Breast Reconstruction”, said Brad Conlan, CEO and co-founder of Bimini Health Tech.

The driving force behind this partnership is a shared commitment to patients and plastic surgeons. By joining forces, GC Aesthetics and Bimini Health Tech aim to elevate women's healthcare and well-being, offering comprehensive support for breast reconstruction needs.

Breast Reconstruction requires dedication and commitment to Women Healthcare. Collectively we will embark on this journey to contribute to women's Health and well-being, partnering with medical professionals around the world.


About GC Aesthetics


GC Aesthetics is a long-established global medical technology company that develops, manufactures, and markets a comprehensive range of proprietary aesthetic and reconstructive products. Throughout its 40-year history, GCA has been dedicated to advancing the science of medical aesthetics and delivering high-quality breast implants for breast augmentation and breast reconstructive surgery. We have sold more than 3 million implants across 70 countries, and our products are supported by published 10-year clinical data.


Learn more at www.gcaesthetics.com


About Bimini Health Tech:


Founded in 2013, Bimini Health Tech is a global leader in the regenerative, aesthetic, plastic and reconstructive surgery sectors. Backed by decades of experience, Bimini is committed to the development, acquisition, and commercialization of innovative products that provide premium solutions for patients and physicians. Our portfolio includes the brands Puregraft® (Adipose Filtration System, Serene Breast Implant, Essence Acellular Dermal Matrix), Healeon®, Dermapose®, and Kerastem®. Supported by over a 100 patents, 20 device clearances and approvals, and over 25 scientific publications, Bimini’s products have been utilized in over 1.5 million procedures worldwide.


Learn more at www.biminihealthtech.com


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20231026545758/en/



Permalink

https://www.aetoswire.com/en/news/2710202335458

Contacts

Carlos Reis Pinto

carlosreispinto@gcaesthetics.com


 

Tecnotree Reports Record Order Book Backed by Strong Deliveries, Promises Stable Growth

 (BUSINESS WIRE) -- Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, announced today its financial results for the quarter ended September 30, 2023.


Key highlights of the third quarter financial results:


Net sales in the third quarter were EUR 21.4 million, showing 7.4% growth compared to last year


Operating results increased 23.0% to EUR 6.2 million as compared to 5.0 last year


Net result decreased by 3.3% to EUR 3.2 million


Cash flow after investments was EUR -7.9 million


Earnings per share were EUR 0.01


Tecnotree received EUR 31 million of new orders for the Quarter and the Order Backlog at the end of the period stood at EUR 78.0 million


Commenting on the results for the third quarter of 2023, Padma Ravichander, CEO of Tecnotree Corporation, said, “We are pleased with our performance this quarter as we maintain an ongoing momentum of consistent growth despite challenging market conditions. This growth was fuelled by deliveries of our Digital Stack for BSS in Africa and the Middle East along with Tecnotree Sensa AI/ML deliveries in Healthcare and Fintech in the United States of America. Our focus remains to keep delivering quality products and services to our customers while ensuring that we monetize all opportunities offered by the market for AIML-led Digital Transformations and B-B-X eco-system play.”


Other significant milestones:


Tecnotree launched MTN D-Stack, under the transformation program MTN Metamorphose powered by Tecnotree. Driven by Tecnotree’s digital suite, the project signifies a major leap towards enhancing MTN’s offerings, enabling them to benefit from wide-ranging automation-driven solutions.


Tecnotree signed a multi-million Euro, 5-year agreement with Telenor Group, to supply Tecnotree Voice Mail System (VMS) for Norway, Denmark and Sweden operations in the Nordic region.


Tecnotree signed a multi-million Euro agreement with Telikom PnG. Under this new agreement, Tecnotree will provide support to Telikom through its BSS-Edge platform, with products like mobile & fixed line business integration.


Tecnotree signed a multi-million Euro deal with a rising telco services provider from the African region. This collaboration will see Tecnotree deliver an advanced digital Business Support Systems (BSS) stack, coupled with Fintech and Value-Added Services (VAS). The new logo is another successful endeavour toward the company’s strong presence in the African region.


This quarter Briclinks Africa Plc ‘BTEL’ selects Tecnotree BSS, Moments B2B2X Marketplace, and Diwa Fintech platform to supercharge Go-to-market, and revenue monetization capabilities.


In addition to this, in Q3 Tecnotree won a Sensa AI/Ml and Digital BSS transformation deal with a Tier-1 CSP in the MENA region.


Tecnotree achieved the Diamond Badge for TM Forum Open API Conformance, solidifying a leading position with a total of 59 certified Open APIs including 9 real world open APIs. The recognition signifies Tecnotree's commitment to creating an open digital ecosystem for customers and matching the increasing expectations of the global communications industry.


Tecnotree has been ranked 4th among the top companies in the world for AI and Autonomous Agents by Markets and Markets Analyst firm in 2023.


Tecnotree has also been ranked among the top 2 vendor companies globally for Revenue Monetisation Market Share in 2023 by Precision Reports and Digital Journal a renowned Canadian analyst firm for CSPs.


Tecnotree was recognized by TM Forum as a finalist in its most prestigious TMF Excellence awards for Customer Experience that was delivered to MTN Uganda.


Tecnotree was honoured with two prestigious awards - ‘Best Innovation in Information Technology’ and 'Best Workplace Diversity Award'. The awards acknowledged Tecnotree’s achievements in the fields of innovation and novel technology implementation, as well as its dedication to fostering exceptional digital talents through workplace diversity.


Additionally, Tecnotree continues its investments in new initiatives – Tecnotree Sensa Fabric AI/ML platform, Tecnotree Moments, Tecnotree DiWa (Digital Wallet), and SaaS; and had successful participation in many global technology events this quarter.


About Tecnotree


Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree is No. 1 on the TM Forum Open API Conformance table with 59 Open APIs, and this is a result of our pursuit towards delivering excellence, and consistently providing differentiated experiences and services to the CSPs and DSPs. Our agile and open-source Digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on the Helsinki Nasdaq (TEM1V). For more information, check our website at www.tecnotree.com


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20231027241013/en/



Permalink

https://www.aetoswire.com/en/news/2710202335473

Contacts

Padma Ravichander, Tecnotree CEO

Email: marketing@tecnotree.com


 

Tecnotree Welcomes Investment Interest from The Royal Front Investments Group

 ESPOO, Finland - Friday, 27. October 2023

(BUSINESS WIRE) -- Tecnotree is pleased to announce that it has received legally binding interest from a consortium of shareholders for EUR 20,000,000. As a part of the consortium, we are pleased to welcome the Royal Front Investments Group, an existing proven partner of the company in the EMEA Region.


Markku Wilenius has confirmed his intention to transfer his unpaid subscriptions rights for his 200 notes to the Consortium to enable proposed transactions.


The parties will now work together over the next 15 days to conclude definitive agreements.


Sina Fattahi, Board Member of Royal Front Investments Group, said, “We have had the pleasure of working with Tecnotree for the past few years and are impressed by the consistent performance of the company. Our commitment to Tecnotree reflects our confidence in the company's potential and its role in the ever-evolving digital landscape. This is a terrific opportunity, and we look forward to working closely with our partners to accelerate Tecnotree's growth and success.”


Padma Ravichander, CEO of Tecnotree Corporation, said, “I am delighted with this significant development, as our journey with the Royal Front Investments Group transforms from a customer relationship to a strategic partnership. This investment is a testament to the value and potential they see in Tecnotree's digital capabilities, growth outlook and strategy. We look forward to working closely with our partners to bring this transaction to fruition, which should only enhance and accelerate our strategic initiatives and technology development efforts.”


Neil Macleod, Chairman of Tecnotree Corporation, said, “This gives Fitzroy Investment an opportunity to increase our investment in Tecnotree and we are committed to the companies long term growth and success. Additionally, as a member of the consortium we are very happy to welcome Royal Front Investments as a significant shareholder to the Tecnotree family and I also thank Luminous Sun Holdings for their continued support of the company.”


About Tecnotree


Tecnotree is a 5G-ready digital Business Support System (BSS) player with AI/ML capabilities and multi-cloud extensibility. The company has over 40 years of deep domain expertise and is amongst the first few to attain the Platinum Badge for Open API standards by TM Forum. Tecnotree's agile and open-source Digital BSS Stack comprises a full range (order-to-cash) of business processes and subscription management services for telecom providers and other digital service providers. The company also offers Fintech solutions and a B2B2X multi-experience digital marketplace through its Tecnotree Moments platform, empowering digitally connected communities across various verticals. Tecnotree is listed on Nasdaq Helsinki (TEM1V). For more information, please visit www.tecnotree.com.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20231027905450/en/



Permalink

https://www.aetoswire.com/en/news/2710202335475

Contacts

Indiresh Vivekananda, CFO, tel. +971 56 410 8357

Rockwell Automation and Microsoft Expand Partnership to Leverage Generative AI Capabilities for Enhanced Productivity and Faster Time-to-Market

 


Industrial organizations will benefit from industry-first Generative AI for automation design


 

(BUSINESS WIRE)--Rockwell Automation, Inc. (NYSE: ROK) and Microsoft Corp. (NASDAQ: MSFT) today announced an extension of their longstanding relationship to accelerate industrial automation design and development through generative artificial intelligence (AI). The companies are combining technologies to empower the workforce and accelerate time-to-market for customers building industrial automation systems. The first outcome of this collaboration will add Microsoft’s Azure OpenAI Service into FactoryTalk® Design Studio™ to deliver industry-first capabilities accelerating time-to-market for their customers building industrial automation systems.


“The skilled labor shortage and ensuing lost productivity is the biggest challenge facing industrial organizations and their service providers today. These shortages are increasing the need, value, and complexity of automation projects when the ecosystem of service providers is less equipped to deliver on time, quality, and budget,” said Matthew Littlefield, President LNS Research. “Generative AI has already proven its ability to capture the imagination and enhance the productivity of workers in a range of IT and business scenarios. Rockwell Automation and Microsoft’s strategic partnership is an exciting and high-potential step forward in addressing these long-term structural challenges.”


Rockwell and Microsoft recognize that using AI to enhance automation across various roles, from decision makers to control engineers and operators, is a key area where they can come together to help customers streamline their processes and drive worker productivity.


“Rockwell’s decade-long relationship with Microsoft illustrates our ongoing commitment to providing best-of-breed solutions that empower customers and support our shared vision of driving industries forward through innovation and collaboration,” said Blake Moret, Chairman and CEO of Rockwell Automation. “Together, we're not just addressing current market needs; we're shaping the future of technology in industrial automation.”


Adding Azure OpenAI Service into FactoryTalk Design Studio helps engineers generate code using natural language prompts, automating routine tasks and improving design efficiency. It will also empower seasoned engineers to accelerate development and mentor newcomers on a learning path more efficiently and effectively. Additionally, it will assist in finding relevant help from vast collections of information to further educate developers. Rockwell and Microsoft see a bright future in extending this integrated technology to solve other challenges, including Quality Management and Improvement, Failure Mode Analysis, and training frontline workers to execute manufacturing processes through chat-based collaboration with experienced human workers as well as Azure Open AI Service-based chatbots.


“The explosive growth and interest in artificial intelligence is driving organizations to partner with Microsoft as a trusted cloud and AI provider,” said Judson Althoff, executive vice president and chief commercial officer at Microsoft. “I am pleased to further strengthen our longstanding relationship with Rockwell by combining its expertise in industrial automation with Microsoft’s generative AI technology to help industrial professionals expedite the creation of complex control systems, optimize the efficiency of their operations, and spur greater innovation across industrial organizations.”


Additionally, Rockwell and Microsoft are continuing to explore ways to advance innovation in the industrial metaverse. Both companies are using their respective IoT capabilities, cloud datasets, simulations and AI to design and build products more effectively, more efficiently, and more sustainably.


The work between Rockwell and Microsoft will be showcased during Rockwell’s 2023 Automation Fair on Nov. 6-9, 2023, in Boston, Massachusetts.


Learn more about this collaboration here.


About Rockwell Automation


Rockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 28,000 problem solvers dedicated to our customers in more than 100 countries. To learn more about how we are bringing the Connected Enterprise to life across industrial enterprises, visit www.rockwellautomation.com.


About Microsoft


Microsoft (Nasdaq “MSFT” @Microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20231026300444/en/



Permalink

https://aetoswire.com/en/news/2610202335441

Contacts

Rockwell Media Relations

Chaya Jacobs, Director, PR & Social Media

CJacobs@ra.rockwell.com

+1 414-305-2784


Microsoft Media Relations

WE Communications for Microsoft

rapidresponse@we-worldwide.com

+1 425-638-7777


 

Friday, October 27, 2023

Boehringer Ingelheim’s SPEVIGO® (spesolimab) wins 2023 Prix Galien USA Best Orphan/Rare Diseases Solution Award

 (BUSINESS WIRE) -- Boehringer Ingelheim today announced that SPEVIGO® (spesolimab) has been recognized as Best Orphan/Rare Diseases Solution of 2023 by the Galien Foundation. The Prix Galien USA Award was presented last night in New York.


Prix Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. In 2022 the U.S. Food and Drug Administration approved spesolimab as a treatment option for GPP flares in adults and the European Medicine Agency granted a conditional market authorization as first-in-class treatment option for GPP flares in adults.


“Being nominated and winning the Prix Galien for SPEVIGO® is a testament to the exceptional work of our research and development teams to bring the first targeted and highly effective immunomodulatory biologic to people living with generalized pustular psoriasis (GPP). We are honored to be recognized among the best of the best in the pharmaceutical industry,” said Michel Pairet, member of the Board of Managing Directors and Head of the Innovation Unit. “Our scientists have achieved deep biological insights into GPP uncovering the key pathway driving the disease, and based on this developed the first specific treatment for GPP flares.”


“SPEVIGO® winning the Prix Galien is a great honor! It reinforces our values and mission to bring innovative treatments better and faster to the people that need it most, especially with rare diseases like GPP. GPP flares may appear suddenly, intensify quickly and can be life-threatening if left untreated, leaving those affected and their loved ones feeling anxious and uncertain about their future. We are humbled by the positive impact SPEVIGO® has had on GPP patients across the world, and take this recognition as a driver to continue our pursuit for their continued benefit,” said Carinne Brouillon, Member of the Board of Managing Directors and Head of Human Pharma at Boehringer Ingelheim.


"We are delighted to extend the Prix Galien legacy to another distinguished cohort of winners who have demonstrated the unparalleled skill, innovation, and dedication required across the life sciences industry,” said Bruno Cohen, Chairman of The Galien Foundation.


Late-breaking data from the EFFISAYIL™ 2 trial presented in 2023 showed that spesolimab prevents GPP flares. It significantly reduced the risk of occurrence of GPP flares by 84% over 48 weeks compared to placebo. Furthermore, the trial with 123 patients demonstrated no flares after Week 4 of spesolimab treatment in the high dose group1. Boehringer Ingelheim has submitted spesolimab for regulatory approval based on these data to, not only provide patients with a specific treatment for GPP flares but moving forward also for the prevention of flares.


Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma and Animal Health. Learn more at www.boehringer-ingelheim.com


Boehringer Ingelheim’s Intended Audiences Notice

This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.


References

1.Morita et al. Lancet. 2023 Sep 19:S0140-6736(23)01378-8.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20231027763389/en/



Permalink

https://www.aetoswire.com/en/news/2710202335471

Contacts

Harro ten Wolde

Phone: +49 151 61901069

Email: press@boehringer-ingelheim.com

EU Organic Journey Showcases European Organic Delights at Biofach Saudi Arabia 2023

 


Biofach Saudi Arabia 2023, the premier organic products exhibition, is set to showcase a diverse array of organic offerings, spanning from fruits and vegetables to dairy products, grains, and meats. This event presents a unique opportunity to explore the latest trends and innovations in the organic sector.


The EU-funded campaign, known as "EU Organic Journey," is on a mission to raise awareness and promote European organic products from Greece, Romania, and Bulgaria. The campaign targets consumers in the UAE, Saudi Arabia, and the USA. It brings together key organizations, including Agrodiatrofiki Sympraxi Perifereias Stereas Elladas (ASPSE) from Greece, Biocarpathia Cooperative from Romania, and the National Organic Association (NAO) from Bulgaria. The featured products include organic virgin olive oil, organic olives, organic honey, organic milk, and organic cheese.


As a part of this remarkable initiative, "EU Organic Journey" will participate in Biofach Saudi Arabia 2023. The event is scheduled to take place from November 19th to 21st, 2023, at the Riyadh International Convention & Exhibition Center, located at King Abdullah Rd, King Abdullah District, Riyadh 11564, Saudi Arabia. They can be found as the "EU Organic Journey" at Hall 3, Booth No F2.


Visitors to the expo will have the unique opportunity to gain insights into European organic production methods, learn more about the featured products, and engage with the participating organizations. This event will also serve as a platform to explore potential business collaborations.


They can be found on social media platforms including Facebook, Instagram, and on their website at euorganicjourney.eu.



Permalink

https://aetoswire.com/en/news/2710202335469

Contacts

Melwyn Abraham - melwyn@matrixdubai.com

MSCI to Reclassify the MSCI Nigeria Indexes from Frontier Markets to Standalone Markets Status

NEW YORK - Friday, 27. October 2023


(BUSINESS WIRE)--MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, announced today that the MSCI Nigeria Indexes will be reclassified from Frontier Markets to Standalone Markets status in one step coinciding with the February 2024 Index Review.


This conclusion follows feedback received from market participants from its recent extended Consultation on a Market Reclassification Proposal for the MSCI Nigeria Indexes.


Since March 2020, liquidity challenges in the Nigerian foreign exchange (FX) market have consistently affected the accessibility of its equity market, leading to ongoing capital repatriation concerns and a significant gap between the official and parallel exchange rates for the Nigerian Naira. This has caused international institutional investors to face recurring challenges with index replicability and investability of the MSCI Nigeria Indexes and other indexes they are part of.


On June 22, 2023, MSCI announced that feedback from market participants obtained as part of the initial consultation conducted from June 2022 to June 2023 suggested that the limited accessibility of the Nigerian equity market would warrant the removal of the MSCI Nigeria Indexes from the MSCI Frontier Markets Indexes. However, MSCI extended the consultation period to September 29, 2023 to allow more time for the liquidity situation in the Nigerian FX market to stabilize following measures announced by the Central Bank of Nigeria on June 14, 2023. No significant improvements in FX liquidity were observed by market participants during the extended consultation period, confirming that the ease of capital inflows and outflows in the MSCI Nigeria Indexes is not to the standards expected from Frontier Markets. This has led to MSCI’s decision to reclassify the MSCI Nigeria Indexes.


In order to facilitate index replicability at the time of the reclassification, MSCI will delete each Nigerian security from the MSCI Frontier Markets Indexes at a price that is effectively zero as of the close of February 29, 2024. More information on this and other details related to the implementation of the reclassification will be shared at a date closer to the reclassification.


About MSCI


MSCI is a leading provider of critical decision support tools and services for the global investment community. With over 50 years of expertise in research, data and technology, we power better investment decisions by enabling clients to understand and analyze key drivers of risk and return and confidently build more effective portfolios. We create industry-leading research-enhanced solutions that clients use to gain insight into and improve transparency across the investment process.


The process for submitting a formal index complaint can be found on the index regulation page of MSCI’s website at: https://www.msci.com/index-regulation.


This document and all of the information contained in it, including without limitation all text, data, graphs, charts (collectively, the “Information”) is the property of This document and all of the information contained in it, including without limitation all text, data, graphs, charts (collectively, the “Information”) is the property of MSCI Inc. or its subsidiaries (collectively, “MSCI”), or MSCI’s licensors, direct or indirect suppliers or any third party involved in making or compiling any Information (collectively, with MSCI, the “Information Providers”) and is provided for informational purposes only. The Information may not be modified, reverse-engineered, reproduced or redisseminated in whole or in part without prior written permission from MSCI. All rights in the Information are reserved by MSCI and/or its Information Providers.


The Information may not be used to create derivative works or to verify or correct other data or information. For example (but without limitation), the Information may not be used to create indexes, databases, risk models, analytics, software, or in connection with the issuing, offering, sponsoring, managing or marketing of any securities, portfolios, financial products or other investment vehicles utilizing or based on, linked to, tracking or otherwise derived from the Information or any other MSCI data, information, products or services.


The user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. NONE OF THE INFORMATION PROVIDERS MAKES ANY EXPRESS OR IMPLIED WARRANTIES OR REPRESENTATIONS WITH RESPECT TO THE INFORMATION (OR THE RESULTS TO BE OBTAINED BY THE USE THEREOF), AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, EACH INFORMATION PROVIDER EXPRESSLY DISCLAIMS ALL IMPLIED WARRANTIES (INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTIES OF ORIGINALITY, ACCURACY, TIMELINESS, NON-INFRINGEMENT, COMPLETENESS, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) WITH RESPECT TO ANY OF THE INFORMATION.


Without limiting any of the foregoing and to the maximum extent permitted by applicable law, in no event shall any Information Provider have any liability regarding any of the Information for any direct, indirect, special, punitive, consequential (including lost profits) or any other damages even if notified of the possibility of such damages. The foregoing shall not exclude or limit any liability that may not by applicable law be excluded or limited, including without limitation (as applicable), any liability for death or personal injury to the extent that such injury results from the negligence or willful default of itself, its servants, agents or sub-contractors.


Information containing any historical information, data or analysis should not be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. Past performance does not guarantee future results.


The Information may include “Signals,” defined as quantitative attributes or the product of methods or formulas that describe or are derived from calculations using historical data. Neither these Signals nor any description of historical data are intended to provide investment advice or a recommendation to make (or refrain from making) any investment decision or asset allocation and should not be relied upon as such. Signals are inherently backward-looking because of their use of historical data, and they are not intended to predict the future. The relevance, correlations and accuracy of Signals frequently will change materially.


The Information should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. All Information is impersonal and not tailored to the needs of any person, entity or group of persons.


None of the Information constitutes an offer to sell (or a solicitation of an offer to buy), any security, financial product or other investment vehicle or any trading strategy.


It is not possible to invest directly in an index. Exposure to an asset class or trading strategy or other category represented by an index is only available through third party investable instruments (if any) based on that index. MSCI does not issue, sponsor, endorse, market, offer, review or otherwise express any opinion regarding any fund, ETF, derivative or other security, investment, financial product or trading strategy that is based on, linked to or seeks to provide an investment return related to the performance of any MSCI index (collectively, “Index Linked Investments”). MSCI makes no assurance that any Index Linked Investments will accurately track index performance or provide positive investment returns. MSCI Inc. is not an investment adviser or fiduciary and MSCI makes no representation regarding the advisability of investing in any Index Linked Investments.


Index returns do not represent the results of actual trading of investible assets/securities. MSCI maintains and calculates indexes, but does not manage actual assets. The calculation of indexes and index returns may deviate from the stated methodology. Index returns do not reflect payment of any sales charges or fees an investor may pay to purchase the securities underlying the index or Index Linked Investments. The imposition of these fees and charges would cause the performance of an Index Linked Investment to be different than the MSCI index performance.


The Information may contain back tested data. Back-tested performance is not actual performance, but is hypothetical. There are frequently material differences between back tested performance results and actual results subsequently achieved by any investment strategy.


Constituents of MSCI equity indexes are listed companies, which are included in or excluded from the indexes according to the application of the relevant index methodologies. Accordingly, constituents in MSCI equity indexes may include MSCI Inc., clients of MSCI or suppliers to MSCI. Inclusion of a security within an MSCI index is not a recommendation by MSCI to buy, sell, or hold such security, nor is it considered to be investment advice.


Data and information produced by various affiliates of MSCI Inc., including MSCI ESG Research LLC and Barra LLC, may be used in calculating certain MSCI indexes. More information can be found in the relevant index methodologies on www.msci.com.


MSCI receives compensation in connection with licensing its indexes to third parties. MSCI Inc.’s revenue includes fees based on assets in Index Linked Investments. Information can be found in MSCI Inc.’s company filings on the Investor Relations section of msci.com.


MSCI ESG Research LLC is a Registered Investment Adviser under the Investment Advisers Act of 1940 and a subsidiary of MSCI Inc. Neither MSCI nor any of its products or services recommends, endorses, approves or otherwise expresses any opinion regarding any issuer, securities, financial products or instruments or trading strategies and MSCI’s products or services are not a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such, provided that applicable products or services from MSCI ESG Research may constitute investment advice. MSCI ESG Research materials, including materials utilized in any MSCI ESG Indexes or other products, have not been submitted to, nor received approval from, the United States Securities and Exchange Commission or any other regulatory body. MSCI ESG and climate ratings, research and data are produced by MSCI ESG Research LLC, a subsidiary of MSCI Inc. MSCI ESG Indexes, Analytics and Real Estate are products of MSCI Inc. that utilize information from MSCI ESG Research LLC. MSCI Indexes are administered by MSCI Limited (UK).


Please note that the issuers mentioned in MSCI ESG Research materials sometimes have commercial relationships with MSCI ESG Research and/or MSCI Inc. (collectively, “MSCI”) and that these relationships create potential conflicts of interest. In some cases, the issuers or their affiliates purchase research or other products or services from one or more MSCI affiliates. In other cases, MSCI ESG Research rates financial products such as mutual funds or ETFs that are managed by MSCI’s clients or their affiliates, or are based on MSCI Inc. Indexes. In addition, constituents in MSCI Inc. equity indexes include companies that subscribe to MSCI products or services. In some cases, MSCI clients pay fees based in whole or part on the assets they manage. MSCI ESG Research has taken a number of steps to mitigate potential conflicts of interest and safeguard the integrity and independence of its research and ratings. More information about these conflict mitigation measures is available in our Form ADV, available at https://adviserinfo.sec.gov/firm/summary/169222.


Any use of or access to products, services or information of MSCI requires a license from MSCI. MSCI, Barra, RiskMetrics, IPD and other MSCI brands and product names are the trademarks, service marks, or registered trademarks of MSCI or its subsidiaries in the United States and other jurisdictions. The Global Industry Classification Standard (GICS) was developed by and is the exclusive property of MSCI and S&P Global Market Intelligence. “Global Industry Classification Standard (GICS)” is a service mark of MSCI and S&P Global Market Intelligence.


MIFID2/MIFIR notice: MSCI ESG Research LLC does not distribute or act as an intermediary for financial instruments or structured deposits, nor does it deal on its own account, provide execution services for others or manage client accounts. No MSCI ESG Research product or service supports, promotes or is intended to support or promote any such activity. MSCI ESG Research is an independent provider of ESG data.


Privacy notice: For information about how MSCI collects and uses personal data, please refer to our Privacy Notice at https://www.msci.com/privacy-pledge.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20231026841096/en/



Permalink

https://www.aetoswire.com/en/news/53700651

Contacts

 

Media Inquiries

PR@msci.com

Melanie Blanco +1 212 981 1049

Konstantinos Makrygiannis +44 (0) 7768 930056

Tina Tan +852 2844 9320


MSCI Global Client Service

EMEA Client Service + 44 20 7618.2222

Americas Client Service +1 888 588 4567 (toll-free)

Asia Pacific Client Service + 852 2844 9333